晚期毒性相关症状与分次剂量影响头颈癌辅助放疗患者的决策后悔
这项横断面研究纳入108例接受手术和辅助放疗的头颈癌患者,通过电话访谈完成决策后悔量表(DRS)和症状条目问卷。40.5%无后悔、30.1%轻度后悔、29.4%中度至强烈后悔;较高DRS评分与较低单次分次剂量及更多日常生活受限最强相关,并与言语困难、吞咽困难、照射区疼痛、对外观不满、感到悲伤和担忧未来健康相关。作者建议提供心理社会支持和充分治疗晚期毒性相关症状,并认为在治疗选择中可优先考虑较高单次分次剂量(即大分割)放疗。
要点
- 108例头颈癌术后辅助放疗患者中,29.4%报告中度至强烈决策后悔。
- 较高DRS评分与较低单次分次剂量及更多日常生活受限关联最强。
- 言语困难、吞咽困难、照射区疼痛、外观不满、悲伤和担忧未来健康也与较高DRS评分相关。
核心结论
- 作者建议接受辅助放疗的头颈癌患者获得心理社会支持和充分的晚期毒性相关症状治疗;面对不同治疗选择时,因较高单次分次剂量(即大分割)与较低决策后悔相关,可优先考虑该放疗方式。
研究设计与样本
- 横断面研究,患者在接受手术和辅助放疗后通过电话访谈完成问卷,问卷包括决策后悔量表(DRS)和若干特定症状条目。
- 共纳入108例患者;截至数据收集时,所有患者完成放疗至少2个月、最长3.3年。
主要发现
- 108例患者中,40.5%报告无后悔,30.1%报告轻度后悔,29.4%报告中度至强烈后悔。
- 较高DRS评分与较低单次分次剂量及更多日常生活受限关联最强。
- 较高DRS评分还与言语困难、吞咽困难、照射区疼痛、对外观不满、感到悲伤和担忧未来健康相关。
临床怎么用
- 作者建议接受辅助放疗的头颈癌患者获得心理社会支持并充分治疗晚期毒性相关症状。
- 作者认为面对不同治疗选择时,因较高单次分次剂量(即大分割)与较低决策后悔相关,可优先考虑该放疗方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Decision regret reflects patient satisfaction with treatment choice and is associated with quality of life. This study aimed to identify patient, tumor, and treatment characteristics and post-treatment symptoms associated with decision regret among patients with head and neck cancer who underwent surgery and adjuvant radiotherapy. METHODS: In this cross-sectional study, patients completed a questionnaire during a telephone interview. The questionnaire included the Decision Regret Scale (DRS) and several specific symptom-related items. By the time of data collection, all patients had concluded their radiotherapy a minimum of 2 months and maximum of 3.3 years prior. RESULTS: Among the 108 patients included, 40.5% reported no regret, 30.1% reported mild regret, and 29.4% reported moderate to strong regret. A higher DRS score was most strongly associated with a lower single fraction dose and more restriction in everyday life. Higher DRS scores were also correlated with trouble speaking, trouble swallowing, pain in irradiated areas, dissatisfaction with one's appearance, feeling sad, and worry over one's future health. CONCLUSIONS: Based on these findings, we recommended that patients with head and neck cancer undergoing adjuvant radiation receive psychosocial support and adequate treatment of late toxicity-related symptoms. When confronted with different therapeutic options, radiotherapy with a higher single fraction dose (i.e., hypofractionation) may be preferred due to its association with lower decision regret.
引用
- Köksal M, Saur L, Scafa D, et al. Late toxicity-related symptoms and fraction dose affect decision regret among patients receiving adjuvant radiotherapy for head and neck cancer. Head Neck. 2022. PMID: 35635498. doi:10.1002/hed.27103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。